日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin®) in patients with advanced solid tumors

KOS-862(Epothilone D)与卡铂(Paraplatin®)联合治疗晚期实体肿瘤患者的 1 期研究

J Paul Monk, Miguel Villalona-Calero, Joe Larkin, Greg Otterson, David S Spriggs, Alison L Hannah, Gillian F Cropp, Robert G Johnson, Martee L Hensley